Most Recent
Judges’ schedules to be cleared as court expedites Johnson & Johnson pelvic mesh appeal
The top judge of the Federal Court plans to clear the schedules of three judges at the start of next year so they can hear and decide Johnson & Johnson's challenge of a class action ruling that found its pelvic mesh devices were defective and awarded the lead applicants $2.6 million in damages.
Government loses case claiming $325M over generic Plavix delay
A court has dismissed a claim by the Australian Government for $325 million against pharmaceutical companies Sanofi and Bristol-Myers Squibb allegedly owed for excess subsidies it paid for blood-thinner Plavix as a result of an interlocutory injunction blocking a generic version of the blockbuster drug.
Celebrity chef Pete Evans fined $25,200 for bogus coronavirus claims about light product
Celebrity chef Pete Evans has been fined $25,200 by the Therapeutic Goods Administration for claiming an expensive light machine dubbed the Biocharger could help protect people from the coronavirus.
Doctors can’t shut down pelvic mesh lawsuit by J&J class action member
Two gynaecologists have lost their bid to dismiss a negligence lawsuit brought by a patient implanted with a Johnson & Johnson pelvic mesh device found by a judge overseeing a related class action to have been defective.
Law firm investigates class action against opioid makers
The makers or popular opioid drugs like OxyContin and Fentanyl may face a class action in Australia by consumers who allege they suffered financial loss from the addictive drugs.
ACCC allows coordination to address COVID-19 ventilator shortages
The Australian Competition and Consumer Commission has taken swift action to allow medical technology companies to coordinate on supplying ventilators, protective gear and other equipment in high demand due to the coronavirus.
Juno halts planned sale of Velcade generic in settlement with Millennium, US
Generic drug maker Juno Pharmaceuticals has agreed to stopped planned sales of its cheap version of Millennium Pharmaceuticals anti-cancer medication Velcade in Australia as part of a settlement of its lawsuit alleging two patents covering the drug were invalid.
AFT loses challenge to ruling over ‘misleading’ Maxigesic ads
AFT Pharmaceuticals has lost its challenge to a ruling that ads claiming its painkiller Maxigesic is more effective than Nuremol were misleading and deceptive, with the Full Federal Court saying the primary judge did not err in finding the ads lacked an adequate scientific basis.
ACCC says cancellations due to COVID-19 could impact consumer rights
The Australian Competition and Consumer Commission has issued guidelines on consumers' rights to refunds if a flight or event is shuttered due to the coronavirus, saying consumer guarantees could be affected if cancellation are caused by government restrictions.
Coronavirus could threaten jury trial in Country Care cartel case
A Federal Court judge has acknowledged concerns raised by the accused in a criminal cartel case against mobility equipment provider Country Care and two employees about how an upcoming jury trial will proceed if the coronavirus pandemic worsens, telling the parties the court had already taken measures to control the spread of the virus.